drugset / Trial / NCT05775094
A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to measure the effect of romosozumab on bone formation and breakdown (resorption) and determine if romosozumab is a safe treatment for osteoporosis and myeloma-related bone disease (MBD) in postmenopausal people with multiple myeloma (MM).
Timeline
- Start
- 2023-03-07
- Primary completion
- 2027-03
- Completion
- 2027-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Romosozumab | Monoclonal antibody | 210 mg | Subcutaneous |